//
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
Mechanisms of Vascular Aging, A Geroscience Perspective JACC Focus Seminar
A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Circadian-Regulated Cell Death in Cardiovascular Diseases
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk